Catalyst Pharm Inc (NQ: CPRX )
14.25 -0.81 (-5.38%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
Press Releases about Catalyst Pharm Inc
Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year
November 07, 2022
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
October 28, 2022
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.
Exposures Securities Market
Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients
September 29, 2022